Unexpected Rosuvastatin-Canagliflozin Adverse Effect Reported

Canadian clinicians report the rare case of a 76-year-old woman who had a sharp spike in plasma levels of rosuvastatin within days of starting the SGLT2 inhibitor. Medscape Medical News
Read More

Leave a Reply

%d bloggers like this: